BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Healy SA, Anderson C, Swihart BJ, Mwakingwe A, Gabriel EE, Decederfelt H, Hobbs CV, Rausch KM, Zhu D, Muratova O, Herrera R, Scaria PV, MacDonald NJ, Lambert LE, Zaidi I, Coelho CH, Renn JP, Wu Y, Narum DL, Duffy PE. Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice. J Clin Invest 2021;131:146221. [PMID: 33561016 DOI: 10.1172/JCI146221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kurtovic L, Reiling L, Opi DH, Beeson JG. Recent clinical trials inform the future for malaria vaccines. Commun Med 2021;1. [DOI: 10.1038/s43856-021-00030-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 de Graaf H, Payne RO, Taylor I, Miura K, Long CA, Elias SC, Zaric M, Minassian AM, Silk SE, Li L, Poulton ID, Baker M, Draper SJ, Gbesemete D, Brendish NJ, Martins F, Marini A, Mekhaiel D, Edwards NJ, Roberts R, Vekemans J, Moyle S, Faust SN, Berrie E, Lawrie AM, Hill F, Hill AVS, Biswas S. Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial. Front Immunol 2021;12:694759. [PMID: 34335606 DOI: 10.3389/fimmu.2021.694759] [Reference Citation Analysis]
3 Howard GP, Bender NG, Khare P, López-Gutiérrez B, Nyasembe V, Weiss WJ, Simecka JW, Hamerly T, Mao HQ, Dinglasan RR. Immunopotentiation by Lymph-Node Targeting of a Malaria Transmission-Blocking Nanovaccine. Front Immunol 2021;12:729086. [PMID: 34512663 DOI: 10.3389/fimmu.2021.729086] [Reference Citation Analysis]
4 Scaria PV, Anderson C, Muratova O, Alani N, Trinh HV, Nadakal ST, Zaidi I, Lambert L, Beck Z, Barnafo EK, Rausch KM, Rowe C, Chen B, Matyas GR, Rao M, Alving CR, Narum DL, Duffy PE. Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques. NPJ Vaccines 2021;6:148. [PMID: 34887448 DOI: 10.1038/s41541-021-00407-3] [Reference Citation Analysis]
5 Takashima E, Tachibana M, Morita M, Nagaoka H, Kanoi BN, Tsuboi T. Identification of Novel Malaria Transmission-Blocking Vaccine Candidates. Front Cell Infect Microbiol 2021;11:805482. [PMID: 34917521 DOI: 10.3389/fcimb.2021.805482] [Reference Citation Analysis]
6 O’flaherty K, Chan J, Cutts JC, Zaloumis SG, Ashley EA, Phyo AP, Drew DR, Dondorp AM, Day NP, Dhorda M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Faiz MA, Mokuolu OA, Onyamboko MA, Fanello C, Takashima E, Tsuboi T, Theisen M, Nosten F, Beeson JG, Simpson JA, White NJ, Fowkes FJI. Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National Study. Front Cell Infect Microbiol 2022;12:804470. [DOI: 10.3389/fcimb.2022.804470] [Reference Citation Analysis]
7 Coelho CH, Galson JD, Trück J, Duffy PE. B cell clonal expansion and mutation in the immunoglobulin heavy chain variable domain in response to Pfs230 and Pfs25 malaria vaccines. Int J Parasitol 2021:S0020-7519(21)00335-0. [PMID: 34896314 DOI: 10.1016/j.ijpara.2021.11.008] [Reference Citation Analysis]
8 Tachibana M, Takashima E, Morita M, Sattabongkot J, Ishino T, Culleton R, Torii M, Tsuboi T. Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation. Parasitol Int 2021;87:102525. [PMID: 34896614 DOI: 10.1016/j.parint.2021.102525] [Reference Citation Analysis]
9 Coelho CH, Tang WK, Burkhardt M, Galson JD, Muratova O, Salinas ND, Alves E Silva TL, Reiter K, MacDonald NJ, Nguyen V, Herrera R, Shimp R, Narum DL, Byrne-Steele M, Pan W, Hou X, Brown B, Eisenhower M, Han J, Jenkins BJ, Doritchamou JYA, Smelkinson MG, Vega-Rodríguez J, Trück J, Taylor JJ, Sagara I, Renn JP, Tolia NH, Duffy PE. A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes. Nat Commun 2021;12:1750. [PMID: 33741942 DOI: 10.1038/s41467-021-21955-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 de Jong RM, Meerstein-Kessel L, Da DF, Nsango S, Challenger JD, van de Vegte-Bolmer M, van Gemert GJ, Duarte E, Teyssier N, Sauerwein RW, Churcher TS, Dabire RK, Morlais I, Locke E, Huynen MA, Bousema T, Jore MM. Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes. NPJ Vaccines 2021;6:101. [PMID: 34385463 DOI: 10.1038/s41541-021-00366-9] [Reference Citation Analysis]